Discover Community Create You

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

Estimating the risk for alpha-1 antitrypsin deficiency among COPD patients: evidence supporting targeted screening.

COPD - 1 Aug 2006

de Serres Frederick J, Blanco Ignacio, Fernández-Bustillo Enrique

Abstract excerpt

Alpha-1 antitrypsin deficiency is known as a significant genetic risk factor for COPD for carriers of phenotype PIMZ, and for phenotypes PIZZ and PISZ. Genetic epidemiological studies for alpha-1 antitrypsin deficiency conducted by others on both COPD patients and concurrent non-COPD controls were used to estimate the risk factors for all six phenotypic classes (namely, the normal phenotype PIMM, and the 5...

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to alpha 1-Antitrypsin Deficiency
Share to Comorbidity
Share to Gene Frequency

Methodology Data sources Editorial policy Privacy About Contact Helena Bioinformatics

Share to Mass Screening

Share to Odds Ratio

Share to Pulmonary Disease, Chronic Obstructive

Share to Risk Factors

Share to Smoking

Source

Identifiers

PMID: 17240615
DOI: 10.1080/15412550600829257

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 7 Sept 2026. Manifest publication-graph-cohort-2026-09-07.1.

Source receipt: pubmed, retrieved 7 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

Estimating the risk for alpha-1 antitrypsin deficiency among COPD patients: evidence supporting targeted screening.PMID 17240615Read ↗

Alpha-1 Antitrypsin PiMZ Genotype Is Associated with Chronic Obstructive Pulmonary Disease in Two Racial Groups.Semantic proximity Read ↗

Prevalence of α1-antitrypsin PiZZ genotypes in patients with COPD in Europe: a systematic review.Semantic proximity Read ↗

Estimated Worldwide Prevalence of the PI*ZZ Alpha-1 Antitrypsin Genotype in Subjects With Chronic Obstructive Pulmonary Disease.Semantic proximity Read ↗

Clarification of the risk of chronic obstructive pulmonary disease in α1-antitrypsin deficiency PiMZ heterozygotes.Semantic proximity Read ↗

Prevalence of alpha-1 antitrypsin high-risk variants in Mexican mestizo population and their association with lung function values.Semantic proximity Read ↗

Alpha-1-antitrypsin deficiency in Serbian adults with lung diseases.Semantic proximity Read ↗

PiSZ alpha-1 antitrypsin deficiency (AATD): pulmonary phenotype and prognosis relative to PiZZ AATD and PiMM COPD.Semantic proximity Read ↗

Alpha-1 Antitrypsin Deficiency in COPD Patients: A Cross-Sectional Study.Semantic proximity Read ↗

Genetic epidemiology of alpha-1 antitrypsin deficiency in North America and Australia/New Zealand: Australia, Canada, New Zealand and the United States of America.Semantic proximity Read ↗

Prevalence of alpha-1 antitrypsin deficiency and allele frequency in patients with COPD in Brazil.Semantic proximity Read ↗

The IDDEA project: a strategy for the detection of alpha-1 antitrypsin deficiency in COPD patients in the primary care setting.Semantic proximity Read ↗

Assessing Inflammatory Protein Biomarkers in COPD Subjects with and without Alpha-1 Antitrypsin DeficiencySemantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.